Novo Nordisk's long-acting insulin Tresiba is set to gain new hypoglycaemia prevention claims in Europe, giving it an advantage over Sanofi’s top-selling Lantus. Europe's CHMP committee has just ...

The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes treatments Tresiba and Ryzodeg. The approval covers all 27 European Union member states. Tresiba (insulin ...

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

NovoLog is a mealtime (rapid-acting) insulin. It’s a brand-name form of insulin aspart. For type 1 diabetes, you’ll typically inject NovoLog before your meals throughout the day. For type 2 diabetes, ...

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 diabetes. Novo Nordisk has resubmitted its biologics license application (BLA ...

Check your blood sugar levels before bed to help prevent nocturnal hypoglycemia. A continuous glucose monitor can alert you to low blood sugar levels while you sleep. Avoid skipping dinner and be ...

Swollen feet can be a symptom of diabetes due to poor circulation and high blood sugar. To reduce swelling, keep your feet elevated, wear compression hose, exercise, and lower salt intake. See a ...